PTPRS was recently shown to dephosphorylate EGFR in the A431 and other cancer cell lines25–27, and a genomic analysis revealed frequent deletion of PTPRS in head and neck cancers was associated with activation of the EGFR/PI3K pathway25. The gene discussed is EGFR; the disease is cancer.